Access cutting-edge human papilloma virus vaccine treatment through this clinical trial at a research site in Alexandria. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Alexandria location
Preparing your pre-screening questions…
Access human papilloma virus vaccine specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related human papilloma virus vaccine treatment provided free
Check if you qualify for this human papilloma virus vaccine clinical trial in Alexandria, VA
No-Cost Study Care
Local to Alexandria
Convenient for VA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Human papillomavirus (HPV) causes 35,900 US cancer cases per year, 4,000 deaths, and $4 billion in can In this study, the investigators will conduct a 3-arm clustered randomized controlled trial (RCT) in an estimated 72 practices from up to 8 health systems to evaluate the effectiveness and cost effectiveness of two potentially scalable implementation strategies (based on prior work) to increase the initiation of HPV vaccine against a usual care (control) arm. The intervention arms are 1) online provider communication training only ("STOP-HPV-Online" and 2) online provider communication training plus a Learning Collaborative, with performance feedback, attended by practice leads ("STOP-HPV-LC). cer-related costs. It is recommended at ages 11-12 years routinely but can be given starting at ages 9-10 years. Despite having an effective vaccine, HPV vaccine initiation/completion rates in the U.S. were only at 76.8%/61.4% respectively in 2023 among 13-17 year olds; these rates are lower than the other recommended adolescent vaccines. Two key barriers are 1) suboptimal clinician communication to address parental concerns and 2) ineffective office systems causing missed vaccine opportunities.
Sponsor: University of California, Los Angeles
Yes, this clinical trial (NCT06831383) has an active research site in Alexandria, VA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for human papilloma virus vaccine treatment options in Alexandria, VA, this clinical trial (NCT06831383) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Alexandria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced human papilloma virus vaccine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all human papilloma virus vaccine clinical trials near you to find additional studies recruiting in your area.
See all vaccine clinical trials recruiting in Alexandria — not just this study.
Browse Vaccine Trials in Alexandria →